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Abstract
Background: Antibiotics are frequently prescribed to children, and may be an environmental influence that
contributes to the increasing prevalence of childhood obesity. The aim of this study was to examine the effect
of antibiotic use in the first year of life on child growth trajectories from birth to age 6 years including significant
covariates.
Methods: Data from 586 children in the Infant Feeding Practices II (IFPS II) and 6 year follow-up study (6YFU) were
included. Antibiotic exposures, weight and height measurements were collected from birth through the first 12
months, and then again at 6 years. Linear mixed effects growth modeling, controlling for exclusive breastfeeding,
socio-demographic factors, smoking during pregnancy, gestational diabetes, and maternal pre-pregnancy weight
status, was used to examine the association between antibiotic exposure and child growth trajectories
through age 6 years.
Results: The majority of infants (60.58%) did not receive any antibiotics; 33.79% received 1–2 courses and
5.63% received 3 or more antibiotic courses during the first year. In the unadjusted model, children with 1–2
antibiotic exposures had a 0.17 (SE 0.08) higher rate of change in BMI z-score (BMIz) than children without
any antibiotics, and children with ≥3 exposures had a 0.42 (SE 0.16) higher rate of change in BMIz (p = 0.009).
Growth trajectory over time for those who had ≥3 antibiotics was greater than those without any antibiotics
(p = 0.002).
Conclusions: Efforts to guide the judicious use of antibiotics should continue, particularly in the first year of life.
Keywords: Antibiotics, Pediatrics, Growth, Weight status, Breastfeeding
Background
Children receive antibiotics in over 20% of ambulatory
visits in the United States. [1] Despite the clear benefits of
antibiotics for specific illnesses, they can also have unin-
tended consequences including antimicrobial resistance [2]
and the development of atopy and inflammatory bowel di-
sease (IBD). [3, 4] Recently, there has been growing interest
in the association between antibiotics and increased weight
status. [5–13] The association between antibiotic exposure
and the development of these chronic diseases is postulated
to be through alterations to the gut microbiota. At this
time, studies have shown that the make-up of the gut
microbiota varies between overweight and normal weight
individuals, [14] and that changes in weight are associated
with changes in the gut microbiota. [15] Often, a higher
proportion of microbiota from the Bacteroidetes phylum
are present in lean individuals and a higher proportion of
Firmicutes in obese individuals. [16–18] Administration of
antibiotics can acutely alter the composition of the gut
microbiota, leading to decreased microbial load and phylo-
genetic diversity, and ultimately the overgrowth of bacteria
that have increased capacity to harvest energy from one’s
dietary intake and promote excess weight gain. [19–21] In
animal studies repeated early antibiotic exposures lead to
perturbations in the gut microbiota and sustained changes
in the metabolic profiles of mice. [22] These changes can
remain for several years and long-term use of antibiotics
may lead to permanent changes in the gut microbiota. [23]
Several human studies have suggested an association
between childhood antibiotic exposure and weight
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status. [5–10, 13, 24–26] These studies have occurred in
the UK, Finland, Denmark, the Netherlands, Canada,
and the US, and have primarily focused on oral anti-
biotic exposure at < 2 years old and risk of obesity be-
tween 2 and 12 years old. While these cohorts have
enhanced our understanding of the relationship between
antibiotics and child weight status, several of them did
not control for key factors known to affect child weight
status and growth, [5, 6, 10, 12, 13] such as maternal
BMI, gestational diabetes, and breastfeeding status.
[27–31] Breastfeeding is associated with the develop-
ment of a gut microbial pattern that may influence
weight gain trajectories and metabolic profiles. Infants
who are breastfed have a lower risk of being over-
weight. Additionally, breastfeeding is associated with
both weight status and antibiotic receipt. [32–34]
Higher maternal weight status and gestational dia-
betes are also associated with increased weight status
[29–31] and has not been included in many of the
previously mentioned studies. [5–7, 10, 12, 13] As
such, it is important to control for these variables as
we examine the relationship between antibiotic use
and early weight gain.
Our goal was to further examine the relationship
between antibiotic use in the first 12 months and its ef-
fect on growth trajectories during the first 6 years. Using
the Infant Feeding Practices II (IFPSII) survey and
6-Year Follow-Up study (6YFU), we aimed to examine
growth trajectories using mixed effects linear regression
models controlling for many of the covariates associated
with childhood obesity and antibiotic use, including
breastfeeding and maternal BMI that have not consist-
ently been included in previous analyses.
Methods
Study sample
Data from the Infant Feeding Practices Study II (IFPS)
[35], which followed mother-infant pairs from late preg-
nancy through the infants’ first year of life, and the 6 year
follow-up study (Y6FU) [36] were included. The study
was conducted by the US Food and Drug Administration
in collaboration with the Centers for Disease Control and
Prevention (CDC) drawing from a nationally distributed
consumer opinion panel from May 2005 to June 2007.
The study was designed to better understand infant feed-
ing practices and factors that influence infant feeding,
infant health, and maternal health and diet. Details regard-
ing the IFPS II have been previously published. [35]
Mothers were eligible to participate in the study if they
were ≥ 18 years old at the prenatal questionnaire, were
having a singleton infant born at ≥35 weeks gestation and
if the infant weighed ≥5 pounds at birth. Neither the
mothers nor the infants were eligible if they had a medical
condition that could impact feeding. Mothers received
questionnaires by mail at 7months gestation, birth, the
neonatal time point (~ 3 weeks old), and post-natal
months 2, 3, 4, 5, 6, 7, 9, 10, and 12. Initially 1807
women completed questionnaires through the first 12
months of life. In 2012, the 6YFU questionnaire was
sent to infant-mother pairs who participated in the
IFPS II study, and a total of 1542 questionnaires were
completed (Fig. 1). [36]
Of the 1542 mothers who completed the 6YFU ques-
tionnaire, only 985 provided the weight, height, and date
of their child’s primary care visit in order for 72 month
BMI z-score to be calculated. Additional subjects were
excluded if infants were less than 37 weeks gestation (n
= 65) or mothers were underweight (BMI < 18.5) at the
pre-pregnancy time point (n = 84). Infants who did not
have anthropometric data (weight and/or length/height)
or the date of the primary care physician visit at 0, 2, 4,
6, 12, and 72months) were dropped from the analysis.
Children with a weight-for-length (WLz) z-score or BMI
z-score less than − 5.0 or greater than 5.0 were consi-
dered outliers and also dropped from the analysis. As a
result, 586 infants were included in the final analysis
(Fig. 1). This study was deemed exempt by the Institu-
tional Review Board of the University of California, San
Diego.
Measures
Exposure
The use of antibiotics during the first year of life was
asked on all questionnaires between 2months and 12
months of age. Mothers were asked a yes/no question:
“Did your baby receive any of the following medicines in
the past 2 weeks?” with “antibiotics” being one of the
options. [37] Infants had anywhere from 0 to 8 courses
of antibiotics in the first year of life. Antibiotic use was
then categorized as none, 1–2 courses, and 3 or more
courses for the analysis.
Outcome
The primary outcome variables were infant WLz at 2,
4, 6 and 12 months and BMI z-score (BMIz) at 72
months. Mothers reported the child’s weight in
pounds and length in inches from the child’s 2, 4, 6,
12 and 72 well-child visit to the primary care pro-
vider. Overweight/Obese status in children at age 6
years was defined by having a BMI z-score ≥ 1.64
(BMI ≥ 95th percentile per CDC guidelines). [38] The
date of each measurement was reported and the
child’s age was determined by calculating the differ-
ence between the infant’s birth date and the reported
date of the primary care visit. Average age at these
visits were: 2 months, 68.32 ± 13.85 days; 4 months,
126.10 ± 15.47 days; 6 months, 191.82 ± 19.07 days; 12
months, 362.38 ± 24.28 days; 72 months, 336.14 weeks
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±10.14 weeks. Infant WLz from 0 to 12 months and
BMIz at 72 months were calculated based on the
2000 Centers for Disease Control and Prevention
(CDC) infant and child growth charts [39].
Covariates
We included several covariates in our model. Maternal
socio-demographic characteristics included maternal
age, race, marital status, annual household income, and
education. Maternal self-reported race was categorized
as white vs. non-white. Marital status was dichotomized
as married vs. single (which included never married, di-
vorced, separated or widowed). Since the median house-
hold income of our sample was $40,000, this variable
was dichotomized into ≥ $40,000 vs. <$40,000. The me-
dian number of years mothers spent in school was 16
years, therefore, maternal education was dichotomized
into ≥16 years (college graduate) vs. < 16 years (some
college or below). Maternal pre-pregnancy weight status
is associated with infant weight gain and growth, [40]
and maternal BMI was divided into one of three
BMI categories: normal weight = 18.50–24.99, over-
weight = 25.00–29.99, and obese ≥30. Gestational dia-
betes has also been associated with overweight status
and was included in the model. [29–31] Mothers
were categorized as having diabetes if they reported
having gestational diabetes, juvenile onset diabetes,
or adult onset diabetes during their pregnancy. Maternal
smoking has been associated with infant weight status and
overweight risk, [41] and was therefore included in the
model. Breastfeeding has been associated with both infant
weight status in childhood, [42] as well as risk of infection
in children. [43] While the American Academy of
Pediatrics (AAP) recommends exclusively breastfeeding
for 6months, most mothers-infant pairs do not exclusively
breast feed for that duration. [44, 45] The CDC National
Immunization Survey reported that only 18.8% of infants
born in 2011 exclusively breastfed for six months while
32.9% exclusively breastfed for four months. [46] There-
fore, we included exclusive breastfeeding for 4months as
a covariate. Infant sex was also included in the model.
Analysis
Statistical analysis was conducted using SAS 9.4 software
(Cary, NC). Means and frequencies were used to de-
scribe the sample. Simple unadjusted bivariate analyses
were conducted using generalized linear models (GLM)
or chi-square statistics to determine whether WLz/BMIz
and covariates differed between the three antibiotic
groups. Using PROC MIXED in SAS and tested for fixed
and random effects, we conducted linear growth model-
ing of 0 (birth), 2-, 4-, 6-, 12- and 72-month assessments
with final models including planned adjustments for co-
variates described above. First we estimated the uncon-
ditional growth model with no covariates to examine the
relative fit of random intercept models with and without
allowance of individual random slopes. Tests of nested
models suggested that adding a random effect for linear
slope improved model fit (− 2 log likelihood decreased
Fig. 1 Study cohort diagram
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from 10,920 to 10,611). Next, we compared the relative
fit of a linear model that also included a term to capture
differences in the rate of acceleration in weight changes
over time with a quadratic effect (time2). The model
with the quadratic effect improved fit significantly (− 2
log likelihood decreased from 10,288 to 10,175) over a
model with only a linear effect of time. Therefore, subse-
quent models included both linear and quadratic effects
to describe changes in WLz/BMIz over time. A dummy
coded index for antibiotic use group was tested to exam-
ine whether there were differences in overall levels of
WLz/BMIz across time points (Model 1) and whether
interactions between antibiotic group and time sug-
gested that the linear or quadratic rate of change in
WLz/BMIz differed across groups (Model 2). The final
model (Model 3) included adjustments for covariates
known to impact infant/child weight status, including
maternal age, maternal BMI, race, marital status, in-
come, education, smoking, diabetes, exclusive breast-
feeding for 4 months, and infant sex. Statistical
significance was set at p ≤ 0.05 for all analyses.
Results
Children had a mean birth weight of 3.50 kg (S.D. 0.46)
(Table 1). By the age of 72 months, 11.09% were either
overweight or obese. Antibiotic use ranged from 0 to 8
courses over the first 12 months. The majority of infants
(60.58%) did not receive any antibiotics; 33.79% received
1–2 antibiotic courses and 5.63% received 3 or more
antibiotic courses during the first year. In total, a little
over half the mothers were either overweight (27.82%)
or obese (23.55%) at the pre-pregnancy time point. Over
half the sample (55.46%) had a college degree or higher,
and 30.21% exclusively breast fed for at least 4 months.
Demographic characteristics of those who received 0, 1–
2, or 3+ antibiotics courses did not differ significantly
from each other except for maternal education. Those
who received 3+ antibiotic courses were more likely to
have a college degree or higher (Table 1).
In the mixed effects linear growth model, we assessed
the effect of linear time, quadratic time and antibiotic
course on child growth (Table 2). In the unconditional
model (not shown), the Intra Class Correlation coefficient
indicated that 25.7% of the variance in growth was
accounted for by differences between children. In model
1, we observed significant increases in WLz/BMIz over
time (linear time; p < 0.0001) and that rates of change in
WLz/BMIz differed across 2-, 4-, 6-, 12- and 72-month as-
sessments (quadratic time; p < 0.0001). Across assess-
ments, infants who had 3+ antibiotics in the first year had
a 0.42 (S.E. 0.16) higher WLz/BMI z-score than infants
who had no antibiotics (p = 0.009). However in Model 2,
we observed a significant interaction between antibiotic
group and the quadratic effect of time (p = 0.003). Infants
who had 3+ antibiotic courses had a more rapid increase
in their rate of growth over time (i.e. the quadratic effect;
p = 0.003). This interaction remained statistically signifi-
cant after adjusting for covariates in Model 3. Figure 2
presents covariate-adjusted changes in WLz/BMIz over
2-, 4-, 6-, 12-, and 72-month assessments for infants in
the antibiotic exposure groups.
Discussion
In this observational cohort study, we found that anti-
biotic use was independently associated with increased
growth during early childhood. The dose-response rela-
tionship between antibiotic exposure and child weight
status, demonstrated in our study and supported by
prior studies [5, 6, 13, 24, 26] provides additional sup-
port for judicious antibiotic prescribing during early
childhood. Finally, evidence of a relationship between
antibiotic exposure and growth trajectory in a US cohort
with good breastfeeding ascertainment is a key contribu-
tion given that breastfeeding has not been included as a
covariate in prior US studies. [5, 6, 12, 24]
It is important to consider that this association held
true while controlling for exclusive breastfeeding status,
a factor thought to affect weight gain in infancy, anti-
biotic prescribing, and gut microbiota composition, and
the impact of antibiotics on the gut microbiome. [27, 47]
Breastfeeding status can be challenging to determine
from health records and therefore, was included in some
[7–9, 25] but not all prior studies in this area. [5, 6,
13, 24] Since the postulated mechanism leading to
the association between antibiotic exposure and
weight status is through the gut microbiota, and
breastfeeding is an important early contributor to the
gut microbiota, [48] inclusion of breastfeeding is key
to understanding this relationship. A study in Finland
found that antibiotic exposure while breastfeeding
may attenuate the beneficial effects of exclusive
breastfeeding, [34] i.e., children who are exposed to
antibiotics may not have the lower weight that would
be anticipated of breastfed babies.
The dose response effect that we found between anti-
biotic exposure and weight status supports the findings
of the majority of the cohorts that evaluated this rela-
tionship previously. A study in Finland examining a
population-based cohort of children under 24 months
old found that children had a 0.18 higher BMIz when
exposed to ≥4 antibiotic courses between 0 and 24
months compared to a 0.10 higher BMIz in those ex-
posed to 2–3 courses. [13] In Central Pennsylvania,
there was a similar dose-response effect for antibiotic
exposure and child BMI when the child’s antibiotic ex-
posure was ≥4 doses for children in the first three years
of life. [24] Additionally, a study conducted among older
children (3–18 years old) in the same Pennsylvania
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health system found a dose-response relationship with
the BMI trajectory of those who received > 7 antibiotic
courses compared to those who received fewer courses.
[6] Another study among children < 5 years old in urban
health centers in Philadelphia found that children also
did not exhibit a dose response relationship until they
received ≥4 courses of antibiotics in the first 24 months
of life. [5] Interestingly, a study in Canada did not find a
dose response relationship between antibiotic exposure
at < 12months and overweight status by the time
children were 12 years old. [7] This result may reflect
differences in how the exposure was assessed (i.e.,
medical record data vs. provincial prescription records).
For an average height 72 month old girl in our cohort
(114 cm), a child exposed to ≥3 courses of antibiotics in
the first year of life would have a 0.82 kg higher weight
than a child who was not exposed to antibiotics in the
first year. This would lead to a 0.4 BMIz score difference
between the two children. While this difference may be
subtle at 72 months old, childhood overweight at 60
Table 1 Sample Characteristics of children and mothers stratified by antibiotic dose categories (n = 586)
Total Sample n = 586 No antibiotics n = 355 1–2 antibiotics n = 198 3+ antibiotics n = 33 p-value
Mother:
Age (years; mean ± SD) 30.95 (±5.12) 30.95 (±5.07) 31.08 (±5.22) 30.24 (±5.08) 0.69
Gestational weight gain (kg; mean ± SD) 13.58 (±5.96) 13.49 (±5.70) 13.81 (±6.05) 13.10 (±8.02) 0.75
Pre-pregnancy WeightStatusa: (%)
Normal weight 48.63 49.01 48.99 42.42 0.73
Overweight 27.82 27.61 28.28 27.27
Obese 23.55 23.38 22.73 30.30
White vs. Other (%) 91.64 90.99 91.41 100.00 0.20
Married vs. Single (%) 88.57 89.01 86.87 93.94 0.46
Income (≥$40,000) (%) 68.77 69.58 65.66 78.79 0.28
Education (≥ college grad) (%) 55.46 57.75 48.99 69.70 0.03
Smoked during pregnancy (%) 5.12 3.94 6.57 9.09 0.23
Gestational Diabetes Mellitusb (%) 9.04 9.30 9.09 6.06 0.82
Exclusive Breast Feeding × 4 mos (%) 30.21 32.85 25.51 30.30 0.20
Vaginal Delivery (%) 69.97 70.42 69.70 66.67 0.90
Infant:
Sex: Male (%) 48.89 49.15 50.00 39.39 0.52
OW/OBc at 72 months (%) 11.09 8.17 14.65 21.21 0.01
Antibiotic Course: (%)
0 60.58
1–2 33.79
3+ 5.63
Birth weight (kg; mean ± SD) 3.50 (±0.46) 3.49 (±0.45) 3.51 (±0.48) 3.48 (±0.44) 0.78
WL z-score (mean ± SD):
0 mos − 0.46 (±1.34) − 0.43 (±1.35) − 0.54 (±1.32) − 0.27 (±1.31) 0.48
2 mos 0.02 (±1.52) − 0.07 (±1.43) 0.15 (±1.68) 0.38 (±1.37) 0.15
4 mos 0.02 (±1.50) − 0.08(±1.47) 0.12 (±1.54) 0.48 (±1.53) 0.10
6 mos 0.17 (±1.64) − 0.02 (±1.59) 0.43 (±1.68) 0.79 (±1.59) < 0.01
12 mos 0.11 (±1.58) − 0.01 (±1.57) 0.32 (±1.59) 0.27 (±1.65) 0.11
BMI z-score (mean ± SD): 72 mos 0.31 (±1.23) 0.24 (±1.15) 0.37 (±1.30) 0.67 (±1.55) 0.14
a Maternal pre-pregnancy weight status was classified by the following definitions: normal weight = 18.5–24.99, overweight = 25–29.99, obese ≥30 (mean = 36.03,
S.D. 5.40)
b Maternal diabetes was defined as self-report of gestational diabetes, juvenile onset diabetes, or adult onset diabetes during or prior to pregnancy
WL z-score =Weight-for-length z-score
BMI z-score = Body Mass Index z-score
cOW/OB = Overweight/Obese; Children were identified as being OW/OB if they had a BMI z-score ≥ 1.64
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Table 2 Linear growth model of Weight-for-Length/BMI z-score from birth to 72 months based on antibiotic exposure during the
first year of life (n = 586)
Model 1 Model 2 Model 3
Estimate (S.E) P-value Estimate (S.E) P-value Estimate (S.E) P-value
Initial WL/BMI z-score (intercept) − 0.21 (0.05) < 0.0001 − 0.18 (0.05) 0.0006 −0.10 (0.35) 0.77
Linear time (months) 0.06 (0.007) < 0.0001 0.04 (0.009) < 0.0001 0.04 (0.009) < 0.0001
Quadratic time (months2) −0.0007 (0.0001) < 0.0001 − 0.0005 (0.0001) < 0.0001 − 0.0004 (0.0001) < 0.0001
Antibiotic course 0.009 0.09 0.10
0 0 0 0
1–2 0.17 (0.08) 0.10 (0.09) 0.08 (0.09)
3+ 0.42 (0.16) 0.37 (0.18) 0.38 (0.18)
Linear Time x Antibiotic course 0.003 0.002
0 0 0
1–2 0.05 (0.02) 0.05 (0.02)
3+ 0.04 (0.03) 0.04 (0.03)
Quadratic Time x Antibiotic course 0.003 0.002
0 0 0
1–2 −0.0007 (0.0002) −0.0008 (0.0002)
3+ −0.0005 (0.0004) −0.0005 (0.0004)
The models presented here included a random statement for the individual allowing variation in intercept, time, time2, and antibiotic course with a variance
components (VC) covariance structure between the effects using a Maximum Likelihood Estimation method. Model 1 includes the effect of time, time2, and
antibiotic dose on weight-for-length/BMI z-score changes from birth to 72months. In Model 2, we included the variables for time x antibiotic course and time2x
antibiotic course. Model 3 controlled for known covariates including maternal age, maternal BMI, race, marital status, income, education, smoking, diabetes,
exclusive breastfeeding for 4 months, and infant sex. Entries show parameter estimates and standard errors in parentheses.
Fig. 2 Growth model examining the effect of antibiotic course on Weight-for-Length/BMI z-score from birth to 6 years. Displays the growth
trajectories of children from birth to 6 years based on the number of antibiotic courses the child received from birth to 12 months. The model
controlled for known covariates for infant/child weight status, including maternal age, maternal BMI, race, marital status, income, education,
smoking, diabetes, exclusive breastfeeding for 4 months, and infant sex
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months old tracks into adolescence [49] and adulthood
[50], therefore, a higher BMIz score at 72 months places
children at a higher risk of overweight in adulthood. We
chose to model growth trajectories over time because it
allowed for a more sensitive analysis of the observed dif-
ferences at 72 months while controlling for the correl-
ation over time between each subject’s weight and height
data. Further studies are warranted to follow children
into adulthood to determine the life course implications
of early and continued childhood antibiotic exposure.
While this study adds to the growing literature that
antibiotic use in infancy may affect weight status in
childhood, there were limitations. The study includes
586 children, and the demographics of the sample are
not representative of the broader US population. [35]
This study was a retrospective observational study
that depended on parental recall of the child’s height
and weight from the doctor’s office, and antibiotic re-
ceipt in the last 2 weeks. [35] Recall bias could impact
the exposure and outcome in our study. However, the
proportion of children with no antibiotic exposure in
the first year of life is similar in this cohort as has
been reported in other studies, [51, 52] and the pro-
portion of children who were overweight/obese is
lower than is reported nationally. Further, each of the
scales utilized, and the individuals completing the
measurements were at different clinical sites which
likely contributed to variability in anthropometric
data. This study does include data on the frequency
of antibiotic use during the first 12 months, which
allowed us to examine the dose-response relationship.
However, we may be underestimating the effect of an-
tibiotics because mothers were not asked to record
any interceding antibiotic courses the child may have
received prior to the past 2 weeks. Furthermore, they
were not asked to report on antibiotic use between
12 months and 6 years, limiting our ability to examine
the effect of continued antibiotic use on later weight
status or weight gain trajectories. Unfortunately, we
were also unable to report on the type of antibiotic
the child received, or the duration of antibiotic use.
This information may have been useful since prior
research reports that broad spectrum antibiotics are
associated with a higher risk of obesity development.
[5] Given these limitations, a prospective study is
warranted to more clearly define the relationship
between antibiotic use and weight status.
Conclusions
Children exposed to antibiotics prior to one year of
age demonstrated a dose-response effect on growth
trajectories while adjusting for key covariates. This
finding contributes to the growing body of literature
that suggests that antibiotic exposure may be
contributing to the prevalence of obesity among chil-
dren, and demonstrates a key area for physicians to
intervene. While we generally think of early childhood
as an important time to treat infections due to the
vulnerability of children with an underdeveloped im-
mune system, the cost of treatment may incorporate
risk for other conditions including obesity and
obesity-associated chronic disease. Therefore, judi-
cious use of antibiotics, especially during the first year
of life, and acknowledging the risk of obesity with ad-
ministration is warranted and required conversation
between physicians and parents.
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